The main purpose of this legislation, known as the Prescription Information Modernization Act of 2025, is to update how prescribing information for drugs, including biological products, is communicated. The goal is to allow this information to be shared primarily through digital means while still ensuring that healthcare providers can access paper copies if they prefer. Key provisions of the law include a requirement that manufacturers of prescription drugs can provide required prescribing information electronically.